256 related articles for article (PubMed ID: 29467323)
1. Von Hippel-Lindau mutations disrupt vascular patterning and maturation via Notch.
Arreola A; Payne LB; Julian MH; de Cubas AA; Daniels AB; Taylor S; Zhao H; Darden J; Bautch VL; Rathmell WK; Chappell JC
JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467323
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel-Lindau disease.
Liang X; Shen D; Huang Y; Yin C; Bojanowski CM; Zhuang Z; Chan CC
Ophthalmology; 2007 Jan; 114(1):147-56. PubMed ID: 17070589
[TBL] [Abstract][Full Text] [Related]
3. Deletion of the von Hippel-Lindau Gene in Hemangioblasts Causes Hemangioblastoma-like Lesions in Murine Retina.
Wang H; Shepard MJ; Zhang C; Dong L; Walker D; Guedez L; Park S; Wang Y; Chen S; Pang Y; Zhang Q; Gao C; Wong WT; Wiley H; Pacak K; Chew EY; Zhuang Z; Chan CC
Cancer Res; 2018 Mar; 78(5):1266-1274. PubMed ID: 29301791
[TBL] [Abstract][Full Text] [Related]
4. Von hippel-lindau disease: a genetic and clinical review.
Haddad NM; Cavallerano JD; Silva PS
Semin Ophthalmol; 2013; 28(5-6):377-86. PubMed ID: 24138046
[TBL] [Abstract][Full Text] [Related]
5. Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma.
Lee JS; Lee JH; Lee KE; Kim JH; Hong JM; Ra EK; Seo SH; Lee SJ; Kim MJ; Park SS; Seong MW
BMC Med Genet; 2016 Jul; 17(1):48. PubMed ID: 27439424
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathology of eyes with von Hippel-Lindau (VHL) Disease: a review.
Chan CC; Collins AB; Chew EY
Retina; 2007 Jan; 27(1):1-7. PubMed ID: 17218907
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis of different von Hippel Lindau mutations: are they related to retinal capillary hemangioblastoma?
Azimi F; Aghajani A; Khakpour G; Chaibakhsh S
Mol Genet Genomics; 2022 Nov; 297(6):1615-1626. PubMed ID: 36006455
[TBL] [Abstract][Full Text] [Related]
8. Extraneuraxial hemangioblastoma: A clinicopathologic study of 10 cases with molecular analysis of the VHL gene.
Muscarella LA; Bisceglia M; Galliani CA; Zidar N; Ben-Dor DJ; Pasquinelli G; la Torre A; Sparaneo A; Fanburg-Smith JC; Lamovec J; Michal M; Bacchi CE
Pathol Res Pract; 2018 Aug; 214(8):1156-1165. PubMed ID: 29941223
[TBL] [Abstract][Full Text] [Related]
9. Von Hippel-Lindau disease (VHL): a need for a murine model with retinal hemangioblastoma.
Park S; Chan CC
Histol Histopathol; 2012 Aug; 27(8):975-84. PubMed ID: 22763871
[TBL] [Abstract][Full Text] [Related]
10. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
[TBL] [Abstract][Full Text] [Related]
11. Von Hippel-Lindau disease: a single gene, several hereditary tumors.
Crespigio J; Berbel LCL; Dias MA; Berbel RF; Pereira SS; Pignatelli D; Mazzuco TL
J Endocrinol Invest; 2018 Jan; 41(1):21-31. PubMed ID: 28589383
[TBL] [Abstract][Full Text] [Related]
12. An 11-bp duplication in the promoter region of the VHL gene in a patient with cerebellar hemangioblastoma and renal oncocytoma.
Muscarella LA; Barbano R; Augello B; Formica V; Micale L; Zelante L; D'Agruma L; Merla G
J Hum Genet; 2007; 52(6):485-491. PubMed ID: 17437055
[TBL] [Abstract][Full Text] [Related]
13. Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene.
Stratmann R; Krieg M; Haas R; Plate KH
J Neuropathol Exp Neurol; 1997 Nov; 56(11):1242-52. PubMed ID: 9370235
[TBL] [Abstract][Full Text] [Related]
14. Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma.
Zhou J; Wang J; Li N; Zhang X; Zhou H; Zhang R; Ma H; Zhou X
Pathol Int; 2010 Jun; 60(6):452-8. PubMed ID: 20518900
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive characterization of a Canadian cohort of von Hippel-Lindau disease patients.
Salama Y; Albanyan S; Szybowska M; Bullivant G; Gallinger B; Giles RH; Asa S; Badduke C; Chiorean A; Druker H; Ezzat S; Hannah-Shmouni F; Hernandez KG; Inglese C; Jani P; Kaur Y; Krema H; Krimus L; Laperriere N; Lichner Z; Mete O; Sit M; Zadeh G; Jewett MAS; Malkin D; Stockley T; Wasserman JD; Xu W; Schachter NF; Kim RH
Clin Genet; 2019 Nov; 96(5):461-467. PubMed ID: 31368132
[TBL] [Abstract][Full Text] [Related]
16. A novel mutation in the VHL gene in a Chinese family with von Hippel-Lindau disease.
Wu X; Chen L; Zhang Y; Xie H; Xue M; Wang Y; Huang H
BMC Med Genet; 2018 Nov; 19(1):204. PubMed ID: 30477447
[TBL] [Abstract][Full Text] [Related]
17. In silico VHL Gene Mutation Analysis and Prognosis of Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease.
Tirosh A; El Lakis M; Green P; Nockel P; Patel D; Nilubol N; Gara SK; Keutgen XM; Linehan WM; Kebebew E
J Clin Endocrinol Metab; 2018 Apr; 103(4):1631-1638. PubMed ID: 29294023
[TBL] [Abstract][Full Text] [Related]
18. Notch receptor and effector expression in von Hippel-Lindau disease-associated central nervous system hemangioblastomas.
Merrill MJ; Edwards NA; Lonser RR
J Neurosurg; 2011 Sep; 115(3):512-7. PubMed ID: 21663414
[TBL] [Abstract][Full Text] [Related]
19. Pathology, genetics and cell biology of hemangioblastomas.
Wizigmann-Voos S; Plate KH
Histol Histopathol; 1996 Oct; 11(4):1049-61. PubMed ID: 8930647
[TBL] [Abstract][Full Text] [Related]
20. von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.
Hoffman MA; Ohh M; Yang H; Klco JM; Ivan M; Kaelin WG
Hum Mol Genet; 2001 May; 10(10):1019-27. PubMed ID: 11331612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
